Related Experiment Video
Updated: Dec 9, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.5K
Multi-slice representational learning of convolutional neural network for Alzheimer's disease classification using
Han Woong Kim1, Ha Eun Lee1, KyeongTaek Oh1
1Department of Medical Engineering, Yonsei University College of Medicine, Seoul, Republic of Korea.
Biomedical Engineering Online
|September 7, 2020
Summary
A new deep learning model accurately diagnoses Alzheimer's disease (AD) using FDG-PET/CT scans. This method is robust across different datasets, showing high accuracy and sensitivity for early AD detection.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Alzheimer's Disease (AD) is a progressive neurodegenerative disorder affecting individuals over 65.
- Accurate and early diagnosis is critical for managing AD, especially given the challenges in advanced stages.
- Existing deep learning methods for AD classification require large datasets and can be sensitive to environmental variations in medical images.
Purpose of the Study:
- To propose a novel deep learning-based method for Alzheimer's Disease diagnosis.
- To develop a model that is less sensitive to dataset variations for external validation.
- To utilize F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging for AD classification.
Main Methods:
- A deep learning network was developed for AD diagnosis using FDG-PET/CT scans.
- The model incorporated a Global Average Pooling (GAP) layer, comparing its performance to a fully connected layer.
- The model was trained and validated on both a proprietary dataset and the publicly available Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
Main Results:
- The proposed network achieved an accuracy of 86.09% and 91.02% on the proprietary and ADNI datasets, respectively.
- Sensitivity and specificity were also high, reaching 80.00% and 92.96% on the proprietary dataset, and 87.93% and 93.57% on the ADNI dataset.
- The GAP layer demonstrated statistically significant superior performance (p < 0.01) compared to the fully connected layer. Crucially, no statistically significant differences in performance were observed between the two datasets (p > 0.05).
Conclusions:
- The proposed deep learning model effectively classifies Alzheimer's Disease using FDG-PET/CT imaging.
- The model's ability to learn AD-specific features from the posterior cingulate cortex (PCC) was confirmed.
- The model's consistent performance across different datasets highlights its robustness and potential for widespread clinical application.
Keywords:
Alzheimer’s diseaseConvolutional neural networkDeep learningExternal validationF-18 FDG-PET/CTFeasibility studyMore Related Videos
Related Concept Videos
Positron Emission Tomography
6.7K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
362
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
362

